Need help now? Support now: crisis lines by country.

Pain words · Mathematical Institute for Research of Pain

Nociplastic pain

Nociplastic pain is pain arising from altered pain processing when no clear tissue damage or disease of the nerves explains it; it is a kind of real pain, not imagined pain.

In plain words

Some pain is not explained by an injury, inflammation or nerve disease that tests can find, yet the pain is real and often widespread. Nociplastic pain is a term that IASP introduced in 2017 for pain of this kind when it is thought to arise from changes in how the nervous system processes pain signals. It names a proposed mechanism, and the criteria for recognising it still need testing.

What researchers mean

IASP defines nociplastic pain as “pain that arises from altered nociception despite no clear evidence of actual or threatened tissue damage causing the activation of peripheral nociceptors or evidence for disease or lesion of the somatosensory system causing the pain”, with the note that patients can have a combination of nociceptive and nociplastic pain. IASP introduced the term in 2017 as a third mechanistic descriptor, beside nociceptive and neuropathic pain (Nijs and colleagues, 2021). In 2021 Kosek and colleagues published clinical criteria and a grading system, possible and probable nociplastic pain, for pain affecting the musculoskeletal system.

The definition rests partly on what is not found. The 2021 criteria are new, and studies testing how well they work are still needed (Nijs and colleagues, 2021). The label describes a proposed mechanism; it does not mean the pain is psychological, and, as the IASP note says, a person can have it together with nociceptive pain.

Nociplastic or neuropathic?

Neuropathic pain needs a demonstrable lesion or disease of the parts of the nervous system that carry and process bodily sensation, in the nerves, spinal cord or brain; symptoms or signs alone, even pain from a light touch, are not enough for that word (see neuropathic pain). Nociplastic pain is the name for pain from altered nociception, the processing of signals about harm, when neither tissue damage nor a lesion or disease of that system explains it.

The 2021 IASP criteria for nociplastic pain affecting the musculoskeletal system, the muscles, joints and bones (Kosek and colleagues, 2021), as Nijs and colleagues (2021) set them out, ask for four things: pain lasting at least three months; pain spread over a region rather than one small, well-defined area; pain that cannot be entirely explained by nociceptive mechanisms (pain from actual or threatened damage to tissue) or neuropathic ones; and signs of pain hypersensitivity found on examination, at least in the painful region, such as allodynia to touch, pressure, heat or cold, or pain that lingers after testing. Meeting all four lets a clinician classify the pain as “possible” nociplastic pain. It becomes “probable” when the person also reports a history of sensitivity to touch, movement, pressure, heat or cold in the painful region and at least one of these: more sensitivity to sound, light or smells; sleep broken by frequent waking; fatigue; or problems with thinking or memory.

The kinds can occur together. Under these criteria nociceptive or neuropathic pain may be present as well, as long as it does not account for all of the pain. Nijs and colleagues note that central sensitisation, a main mechanism proposed for nociplastic pain, has been found in subgroups of people with conditions such as fibromyalgia, whiplash, osteoarthritis, migraine, irritable bowel syndrome and low back pain. Having one of those diagnoses does not, by itself, show whether central sensitisation is present. The difference between allodynia and hyperalgesia is explained on its own page.

These pages explain words, reasoning and evidence. Nothing here is medical advice or a forecast about any person.

Sources

  1. International Association for the Study of Pain. Terminology (definitions of pain terms, with notes). IASP, online edition. iasp-pain.org
  2. Nijs J, Lahousse A, Kapreli E, et al. Nociplastic pain criteria or recognition of central sensitization? Pain phenotyping in the past, present and future. J Clin Med. 2021;10(15):3203. doi:10.3390/jcm10153203
  3. Kosek E, Clauw D, Nijs J, et al. Chronic nociplastic pain affecting the musculoskeletal system: clinical criteria and grading system. Pain. 2021;162(11):2629–2634. doi:10.1097/j.pain.0000000000002324

Questions about this

Inside the Institute

Pain math explains what the Institute does, and Questions about pain answers some questions people in pain ask, in the same layers. The rooms, the Lab and the full Pain Bias Codex open with an invite code.

No code yet? Ask for an invite. A person reads every request and writes back by hand with an invite code, so it may take a few days.

Need help now? Support now: crisis lines by country.

Except where a page says otherwise, the Institute’s own text and figures are shared under CC BY-NC 4.0. Pictures and quotations from others keep their own credits and licences.

Back to the invite page · Sign in

Paper